MedPath

REMDANTRY

REMDANTRY

Approved
DIN Number

02419475

Drug Class

Human

Market Date

Sep 4, 2014

Company
HC

Celltrion Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02419475
AIG Number0144162001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription ,  Schedule D
A
ATC Code
L04AB02 INFLIXIMAB
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification90:24.16.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

INFLIXIMABActive
Strength: 100 MG / VIAL
Monograph: INFLIXIMAB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.